Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Canji issued two patents for p53 gene therapy for cancer

July 12, 1996

Arizona Board of Regents reports antitumor pentapeptides

July 12, 1996

Potent tyrosine kinase inhibitors derived from PD-089828

July 12, 1996

Protein farnesyltransferase inhibitor in Warner-Lambert's compound library

July 12, 1996

PD-158780: A potent and selective EGF tyrosine kinase inhibitor

July 12, 1996

Protein tyrosine kinase inhibitors from Warner-Lambert

July 12, 1996

Arimidex approved for Austrian, German and Italian markets

July 12, 1996

Taxotere approved in eight countries for two indications

July 12, 1996

Yoshitomi and Yamasa Shoyu out-license DMDC

July 12, 1996

Vertex begins phase II study of VX-710

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...